GHdC Site Saint-Joseph
Gilly (Charleroi) 6000
0 studies enrolling now · 2 studies all time
What they study most
Metastatic Breast Cancer, Rheumatoid Arthritis
Studies at this site
- A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
- Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer — Completed